Mild Cognitive Impairment
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
50 companies ranked by most advanced pipeline stage
+20 more companies
Trial Timeline
Clinical trial activity over time
Showing 15 of 50 trials with date data
Clinical Trials (50)
Total enrollment: 6,428 patients across 50 trials
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
Evaluation the Effect of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular Disease
A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment
Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Mild Cognitive Impairment in Early Recovery Stage After Ischemic Stroke
Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease
Clinical Trial of AGB101 for Mild Cognitive Impairment
CBD for Individuals at Risk for Alzheimer's Disease
A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease
A Novel Computer-Based Functional Skills Assessment and Training Program
Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)
Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD
Impact of Grape Consumption on Brain Metabolism and Neuropsychological Performance Over 1 Year
Beta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCI
Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease
Comparison of PET Amyloid Imaging in Japanese and Western Subjects
A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment
Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)
Rosiglitazone Effects on Cognition for Adults in Later Life
Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients
Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment.
Protecting Alzheimer Caregivers Using Technology Through Staying Sharp
Safety and Target Engagement of Centella Asiatica in Cognitive Impairment
Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy
Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive Impairment
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.
Study for the Use of TKIs for Treatment of Cognitive Decline Due to Degenerative Dementias
Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations
Impact of Grape Consumption on Brain Metabolism and Cognitive Function
Conversations as a Means to Delay the Onset of Alzheimer's Disease
An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.
Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers
Exploring Feasibility, Acceptability and Impact of Using Neurofeedback with Persons with Mild Cognitive Impairment
Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)
The Feasibility and Effect of Digital Cognitive Training in Mild Cognitive Impairment
Resistance Training to Individuals for Cognitive Impairment With Dementia
Remote Game-based Exercise Program for Cognitive and Motor Function Improvement
engAGE: Managing cognitivE decliNe throuGh Theatre Therapy, Artificial Intelligence and Social Robots drivEn Interventions
A Study of Dual-task Exercise Training to Prevent Falls Among Older Adults With Mild Cognitive Impairment
Effects of Walkasins on Gait Speed of Individuals With Mild Cognitive Impairments
Multi-domain Online Therapeutic Investigation Of Neurocognition (MOTION)
Development of an EEG Diagnostic for Alzheimer's Disease
Virtual Exercise For Older Adults With Mild Cognitive Impairment
Alzheimer's and Blood Glucose Levels
Evaluation of Cognitive State in Senior Subjects Using Neurosteer EEG System
Maintaining Independence and Quality of Life in Aging Adults Through Targeted Cognitive Training
Effect of High Frequency/Low Intensity Transcranial Magnetic Stimulation in Cognitive Traits of an Elderly Population of Subjects With Mild Cognitive Impairment and Mild Dementia.
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.